Retrospective and prospective analysis of functional and anatomical outcome following chromevitrectomy and peeling
Recruiting
- Conditions
- H35.3Degeneration of macula and posterior pole
- Registration Number
- DRKS00014597
- Lead Sponsor
- Augenklinik Sulzbach
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
epiretinal membrane, pucker, vitreomacular traction
Exclusion Criteria
n/a
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety after 3 months with visual acuity (BCVA) and anatomical ouctcome (optical coherence tomography)
- Secondary Outcome Measures
Name Time Method outcome, BCVA
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are affected by chromevitrectomy in macular degeneration (H35.3) patients?
How does chromevitrectomy compare to standard vitrectomy for epiretinal membrane removal in H35.3 cases?
Which biomarkers correlate with anatomical recovery after chromevitrectomy and posterior pole peeling?
What are the long-term adverse events of chromevitrectomy in degenerative macular disease management?
Are there combination therapies with chromevitrectomy that improve visual acuity in H35.3 patients?